SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Neurorehabilitation and Neural Repair
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hoffmann, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffmann, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Other

Higher Cortical Function Deficits After Stroke: An Analysis of 1,000 Patients from a Dedicated Cognitive Stroke Registry

Michael Hoffmann

Objective: Despite spectacular success of animal model neuroprotective therapy in stroke, these agents have been uniformly unsuccessful in humans. One possible ex planation is the crudity of cerebral measurement by insensitive of stroke scales com prising scant or absent higher cortical-function parameters and the heterogeneity of stroke syndromes and etiology. We sought to determine the frequency and extent of cognitive disorders after stroke and their relation to stroke risk factors, syndromes, le sion site, and etiology. Methods: We used hospital-based consecutive stroke cases. A tiered, hierarchic, cerebrovascular investigative protocol and a battery of predefined, validated bedside higher cortical function deficit (HCFD) tests with comparison to neuropsychological. Quantification according to the World Health Organization lev els of disease model was achieved by a clinical neurologic deficit scale, etiologic scale, and disability scale. Results: Stroke deficit, disability and etiology: In patients evaluated (n = 1,000), the admission Canadian Neurological Scale deficit grading was mild, 11.5-9.5 (n = 696); moderate, 9.5-5.5 (n = 204); and severe, 5.0-0 (n = 86); with correlation to Rankin scale of independent (n = 467), mild disability (n = 345) and severe disability (n = 174) with moderate agreement (kappa = 0.54) between the two measurements. The etiologic subtypes included large-vessel atherothrombosis (n = 264), small-vessel atherothrombosis (n = 262), cardioembolic (n = 122), other (dis section, vasculitis, prothrombotic states; n = 253), and unknown (n = 99). Cognitive Data: 1. One or more higher cortical function abnormalities was detected in 607 (63.5%) of 955 nondrowsy patients. The most numerous categories were aphasias (25.2%), apraxias (14.5%), amnesias (11.6%), and frontal network syndromes (9.2%), with the other categories less frequent (3%). Cognitive impairment occurred without elementary neurologic deficits (motor, sensory, or visual impairment) in 137 (22.5%) of 608. The cardloembolic, other, and unknown stroke mechanistic groups differed sig nificantly from the other groups in terms of HCFD (p = 0.01) frequency. HCFD did not differ between younger (younger than 49 years) and older patients (p = 0.194). 3. Univariate and multivariate analyses of risk factors and likelihood of developing an HCFD revealed increasing age, black race, being overweight, and recent infection to be independent variables (p = 0.05). 4. In 76 patients, neuropsychological testing was performed and comparison with the HCFD test revealed a sensitivity of 80.2% (CI, 72-88%) and specificity of 100%. Conclusions: 1. Cognitive impairment is pres ent in the majority of all types of stroke. 2. Cognitive impairment may be the sole pres entation of stroke, unaccompanied by long-tract signs. 3. Stroke etiologic subtype dif fered significantly among the subgroups, but in comparison of young versus older patients, no significant differences in HCFD frequency were recorded. 4. Risk factors for developing cognitive impairment in the indigenous stroke population included increasing age, black race, overweight body habitus, and recent infection. Key Words: Stroke—Cognitive deficit—Higher cortical function.

Neurorehabilitation and Neural Repair, Vol. 15, No. 2, 113-127 (2001)
DOI: 10.1177/154596830101500205


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Neurorehabil Neural RepairHome page
B. M. Quaney, L. A. Boyd, J. M. McDowd, L. H. Zahner, Jianghua He, M. S. Mayo, and R. F. Macko
Aerobic Exercise Improves Cognition and Motor Function Poststroke
Neurorehabil Neural Repair, November 1, 2009; 23(9): 879 - 885.
[Abstract] [PDF]


Home page
StrokeHome page
A. Jaillard, B. Naegele, S. Trabucco-Miguel, J. F. LeBas, and M. Hommel
Hidden Dysfunctioning in Subacute Stroke * Supplemental Appendix
Stroke, July 1, 2009; 40(7): 2473 - 2479.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
K. Nokleby, E. Boland, H. Bergersen, A.-K. Schanke, L. Farner, J. Wagle, and T. B. Wyller
Screening for cognitive deficits after stroke: a comparison of three screening tools
Clinical Rehabilitation, December 1, 2008; 22(12): 1095 - 1104.
[Abstract] [PDF]



Advertisement